Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

Blood and Nerve Supply to the Bones

Blood and Nerve Supply to the Bones

Bones are dynamic organs that require a rich supply of oxygen and nutrients. Around 5% to 10% of the cardiac output supplies blood to the bones. A typical long bone has three main sources: the nutrient artery, the metaphyseal and epiphyseal arteries, and the periosteal arteries.
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Treatment with Daratumumab in Combination with Glucocorticosteroids as First-Line Treatment Achieves a Complete Remission for a Patient with Multiple Myeloma and Resolves Neutropenia: A Case Report.

Case reports in oncology·2026

Same author

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same author

Serum B-Cell Maturation Antigen as a Biomarker for Predicting Outcomes and Monitoring Patients With Waldenström Macroglobulinemia.

European journal of haematology·2025

Same author

Outcomes for unselected, newly diagnosed multiple myeloma patients.

Haematologica·2025

Same author

Medical writing bias in myeloma clinical research: A comprehensive analysis.

Perspectives in clinical research·2025

Same author

Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.

JCO precision oncology·2025

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Models of Bone Metastasis

Models of Bone Metastasis

Published on: September 4, 2012

Pathophysiology of bone metastases.

James R Berenson¹, Lakshmi Rajdev, Michael Broder

¹Institute for Myeloma and Bone Cancer Research, West Hollywood, California, USA. jberenson@imbcr.org

Cancer Biology & Therapy

|October 3, 2006

Summary

Bone metastases disrupt normal bone remodeling by altering the OPG-RANKL-RANK pathway, leading to increased osteoclast activity and bone loss. This creates a vicious cycle promoting tumor growth and severe osteolysis.

Area of Science:

Oncology
Orthopedics
Cell Biology

Background:

Normal bone remodeling relies on a balance between osteoclasts and osteoblasts.
Skeletal malignancies, particularly bone metastases, disrupt this balance.
The OPG-RANKL-RANK signaling pathway is crucial for regulating osteoclastogenesis.

Purpose of the Study:

To elucidate the role of the OPG-RANKL-RANK pathway in tumor-induced osteolysis.
To understand the mechanisms driving the vicious cycle in bone metastases.
To identify therapeutic targets for managing skeletal complications.

Main Methods:

Analysis of the OPG-RANKL-RANK signal transduction pathway in the context of bone metastases.
Investigation of osteoclast and osteoblast activity in affected bone tissue.

More Related Videos

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Related Experiment Videos

Last Updated: Jul 19, 2026

Models of Bone Metastasis

Models of Bone Metastasis

Published on: September 4, 2012

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

Evaluation of the interplay between tumor cells and bone cells.

Main Results:

Bone metastases disrupt the OPG-RANKL-RANK system, promoting excessive osteoclast formation.
Enhanced osteoclast activity leads to accelerated bone resorption and osteolytic lesions.
Tumor cells and osteoclasts engage in a cycle that fuels both bone loss and tumor progression.

Conclusions:

Tumor-induced alterations in the OPG-RANKL-RANK pathway are the primary cause of osteolytic complications in bone metastases.
The described vicious cycle exacerbates bone resorption and promotes aggressive tumor behavior.
Targeting the OPG-RANKL-RANK system offers potential therapeutic strategies for bone metastases.